The Journal of mHealth Vol 2 Issue 1 (February 2015) | Page 18
Industry News
Oracle and Proteus Integrate
Digital Health Feedback System
to Help Increase Clinical Trial
Accuracy
Designed to help health sciences organisations more effectively track and manage the use of medication during clinical
trials, Oracle has introduced the Health
Sciences InForm Medication Adherence Insights Cloud Service. The solution which integrates the innovative and
market-proven Proteus Digital Health
"smart pill" system automatically sends
medication ingestion data directly into
the Oracle Health Sciences InForm
study database.
The solution is a result of a strategic
relationship between Oracle and Proteus Digital Health which combines
Oracle’s industry-leading clinical data
capture and management system, Oracle
Health Sciences InForm, with the Proteus Digital Health feedback system to
create an innovative product that helps
pharmaceutical developers accelerate
time to market while reducing costs and
improving safety.
The platform helps researchers more accurately and efficiently
track and manage the use of medication during clinical trials—a
historically laborious and error-ridden process. The new solution automates data collection and captures accurate medication
ingestion information.
By providing direct and rapid validation of the quantity of
medication a patient ingests and the time of ingestion, the service can help health sciences organisations lower the risk of
clinical trial failures by identifying medication adherence issues
early, improving dosage decisions, and enhancing drug safety.
This helps to accelerate trials and reduce costs by eliminating
imprecise, time-consuming, and expensive manual processes for
collecting adherence data, such as pill counts and patient questionnaires.
“The medication adherence option uniquely addresses the most
critical information in a clinical trial: ‘Did the patients use their
medicine properly?’ Combining this powerful new data with the
technology, analysis, and capabilities of Oracle Health Sciences
creates a game-changing opportunity for drug development,”
said Markus Christen, head of global development, Proteus
Digital Health.
16
February 2015
Highly engaged patients that consistently take their prescribed
medications as directed are the cornerstone of a successful
clinical trial. Researchers have long struggled to effectively and
efficiently validate adherence—relying on an arduous and often
inaccurate combination of self-reporting and lab tests. This solution not only enables clinical trial sponsors to automatically capture precise and timely data about medication adherence, it can
also help accelerate insight about drug efficacy and safety and
speed clinical trials, which can, in turn, increase trial success rates.
“Oracle Health Sciences InForm Medication Adherence
Insights Cloud Service helps health sciences organisations effectively address two long-standing and complex challenges: measuring participant adherence to drug protocols and identifying
the optimum dosing regimen for recommended use,” said Steve
Rosenberg, senior vice president and general manager, Oracle
Health Sciences. “This groundbreaking solution—the direct
result of a collaboration between Oracle and Proteus Digital
Health—is a powerful example of how we can rapidly combine
our industry-leading clinical trial data capture and management
solutions with emerging technologies, such as digital pills, to
help health sciences organisations transform the drug development and approval process.” n